17 results
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
Antiplatelet Medications ... - Summary Table ... Limited use peri-PCI ... #Summary #Table ... #Pharmacology
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents ... 2020 #Drugs #Medications ... #Pharmacology # ... Table #Management
Anti-infective stewardship, including tips for using anti-infectives wisely, criteria for stepdown from IV to PO dosage
#pharmacology #antibiotics ... #medications #table ... #treatment #drugs
Common Medications Known to Prolong QTc
Antiarrhythmics - Amiodarone, sotalol, flecainide, quinidine, dronedarone, dofetilide
Vasopressors/inotropes - Epinephrine, norepinephrine,
Common Medications ... , venlafaxine Antibiotics ... #Causes #differential ... #diagnosis #pharmacology ... #table
Drug-Induced Seizures - OTIS-CAMPBELL

O - Organophosphate, oral hypoglycemics, opioid
T - TCA, theophylline
I - Isoniazid, Insulin
S -
anticholinergics, amantadine, antibiotics ... /insecticides, PCP ... Induced #Seizures #Medication ... #Causes #Differential ... #Pharmacology #
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Clindamycin in case of PCN ... once stable - ... shows a small, stable ... Lung Abscess Differential ... Abscess #pulmonary #differential
Sulfonamides - Antibiotics Class Overview

BACTRIM/SEPTRA (TMP/SMX) - inhibit sequential steps in Folate synthesis --> bacteriostatic

Spectrum: Wide
Sulfonamides - Antibiotics ... Class Overview ... choice, both for treatment ... #Pharmacology #Antibiotics ... #Review #Overview
Macrolides - Erythromycin, Clarithromycin, Azithromycin - Antibiotics Class Overview

50S Ribosomal Inhibitor (PO and IV)
Spectrum: Atypical organisms
Azithromycin - Antibiotics ... Class Overview ... Strep throat in PCN ... Used for MAC treatment ... #Pharmacology #Antibiotics
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Equina Syndrome Overview ... constipation Differential ... bladder for urinary retention ... axial T1 and T2 Treatment ... Equina #syndrome #differential
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Inhibitors of Na+K+2Cl ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology ... #Medications #Table